Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib.
Muñoz-Mármol AM, Meléndez B, Hernandez A, Sanz C, Domenech M, Arpí-Llucia O, Gut M, Esteve A, Esteve-Codina A, Parra G, Carrato C, Aldecoa I, Mallo M, Pineda E, Alameda F, de la Iglesia N, Martinez-Balibrea E, Martinez-Cardús A, Estival-Gonzalez A, Balana C.
Muñoz-Mármol AM, et al.
Cancers (Basel). 2025 Jan 23;17(3):375. doi: 10.3390/cancers17030375.
Cancers (Basel). 2025.
PMID: 39941744
Free PMC article.